amiodarone has been researched along with Hyperlipoproteinemia in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"To study the effect of hyperlipoproteinemia on in vitro distribution of amiodarone (AM) and its prevalent metabolite desethylamiodarone (DEA) in human and rat plasma." | 7.74 | The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma. ( Brocks, DR; Lee, SD; Shayeganpour, A; Wasan, KM, 2007) |
"To study the effect of hyperlipoproteinemia on in vitro distribution of amiodarone (AM) and its prevalent metabolite desethylamiodarone (DEA) in human and rat plasma." | 3.74 | The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma. ( Brocks, DR; Lee, SD; Shayeganpour, A; Wasan, KM, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shayeganpour, A | 1 |
Lee, SD | 1 |
Wasan, KM | 1 |
Brocks, DR | 1 |
1 other study available for amiodarone and Hyperlipoproteinemia
Article | Year |
---|---|
The influence of hyperlipoproteinemia on in vitro distribution of amiodarone and desethylamiodarone in human and rat plasma.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cholesterol; Humans; Hyperlipoproteinemias; Lipoprotein | 2007 |